A year at the forefront of plasmodesmal biology
Biology Open · 2023
DOI: 10.1242/bio.060123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology Open, 2023. Verfasst von Andrea Paterlini. Beteiligte Einrichtung: Institute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, UK. Hauptthemen laut MEDLINE: Plasmodesmata, Cell Communication. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cell–cell communication is a central feature of multicellular organisms, enabling division of labour and coordinated responses. Plasmodesmata are membrane-lined pores that provide regulated cytoplasmic continuity between plant cells, facilitating signalling and transport across neighboring cells. Plant development and survival profoundly depend on the existence and functioning of these structures, bringing them to the spotlight for both fundamental and applied research. Despite the rich conceptual and translational rewards in sight, however, the study of plasmodesmata poses significant challenges. This Review will mostly focus on research published between May 2022 and May 2023 and intends to provide a short overview of recent discoveries, innovations, community resources and hypotheses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, UK.
ORCID-Profile: Andrea Paterlini
Zitieren
APA
Paterlini, A. (2023). A year at the forefront of plasmodesmal biology. Biology Open. https://doi.org/10.1242/bio.060123
Vancouver
Paterlini A. A year at the forefront of plasmodesmal biology. Biology Open. 2023. doi:10.1242/bio.060123
BibTeX
@article{Paterlini2023,
author = {Paterlini, Andrea},
title = {A year at the forefront of plasmodesmal biology},
journal = {Biology Open},
year = {2023},
doi = {10.1242/bio.060123}
}
EUVIMED